Dr. Kerri Elyse Rieger, MD, PhD

Dr. Rieger practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Rieger's NPI, 1336333475, was assigned on August 31, 2007. Dr. Rieger graduated from Stanford University School Of Medicine in 2005. Dr. Rieger holds California license A101071.

Dr. Rieger's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Rieger's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Rieger is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Rieger to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Rieger's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rieger practices, 8 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Rieger's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Rieger is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Rieger's licenses on file in 2 states: California and Oklahoma.

CMS data shows 8,556 Medicare services from Dr. Rieger across 22 procedure codes in 2024, for 2,871 Medicare patients. Medicare paid $271,464 for them.

CMS counts 2,871 Medicare patients who saw Dr. Rieger in 2024. The largest group is 65 to 74, with 1,157 patients. 73% of them have high cholesterol, and 65% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rieger's median patient age at 54, with 52% women.

In 2024, Dr. Rieger wrote 115 Medicare Part D claims for 24 patients. 91% of them were for generic drugs. CMS names the drug for 39 of them, across 2 drugs with 11 or more claims each, at $580 in total drug cost. In 2023, CMS named 59 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Rieger for performance year 2024, reported as part of a group. Dr. Rieger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 141 procedures of removal of skin lesions by Dr. Rieger, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 113 papers to Dr. Rieger, published from 2004 to 2025. 2024 was the busiest year, with 13. The most frequent topics are Skin Neoplasms, Diagnosis, Differential and Immunohistochemistry. Dr. Rieger has published most often in J Cutan Pathol. Dr. Rieger's most frequent co-authors are Roberto Andres Novoa, MD, Ryanne A. Brown, MD and Bernice Yu Jing Kwong, MD.

CMS Open Payments shows 14 general payments to Dr. Rieger from 2 drug and device companies from 2019 to 2023. Consulting fees make up the largest share, 89% of the total. Kyowa Kirin, Inc. paid the most, $32,282. It also lists 2 research payments totaling $3,530 from 2023 to 2024.

Dr. Rieger graduated from Stanford University School Of Medicine in 2005.

Dr. Rieger is in network with 8 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.